ISOSCELES PHARMACEUTICALS
Isosceles Pharmaceuticals is an preclinical stage biotech developing a perioperative acute pain product candidates using actives with an approved drug master file and an excellent safety profile.
ISOSCELES PHARMACEUTICALS
Social Links:
Industry:
Biotechnology
Address:
Wilmington, North Carolina, United States
Country:
United States
Website Url:
http://www.isoscelespharma.com
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Current Employees Featured
Official Site Inspections
http://www.isoscelespharma.com
- Host name: 151.101.2.159
- IP address: 151.101.2.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Isosceles Pharmaceuticals"
About Us - Isosceles Pharmaceuticals, Inc.
137 Americans die every day from an opioid overdose, approximately 1 American dead every 10 minutes.. Overall, drug overdose deaths rose from 2018 to 2019 with 70,630 drug overdose deaths reported in 2019.. This has increased …See details»
Isosceles Pharmaceuticals - Crunchbase Company …
Isosceles Pharmaceuticals is an preclinical stage biotech developing a perioperative acute pain product candidates using actives with an approved drug master file and an excellent safety profile.See details»
UNITED STATES SECURITIES AND EXCHANGE COMMISSION …
Date of organization April 12, 2019 Physical address of issuer 1213 Culbreth Dr. Suite 359 Wilmington, NC 28405 Website of issuer www.isoscelespharma.com Address of counsel to …See details»
Isosceles Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Www.isoscelespharma.com. Startups | Private Company | 2019 | North Carolina, United States | 10-50 | www.isoscelespharma.com. Last update 01 Nov 2024. ... and Bill’s appointments bring …See details»
Isosceles Pharmaceuticals - PitchBook
Publication ID Patent Title Status First Filing Date Technology (CPC) Citations; US-20220193004-A1: Parenteral cannabinoid formulations and uses thereofSee details»
Contact Us - Isosceles Pharmaceuticals, Inc.
For Investor Relations, please email [email protected].. Menu. About Us; Team; Pipeline; ESG Impact Investing; News; Contact UsSee details»
Isosceles Pharmaceuticals - LinkedIn
Isosceles Pharmaceuticals is an preclinical stage biotech developing a perioperative acute pain product candidates using actives with an approved drug master file and an excellent safety …See details»
Isosceles Pharmaceuticals - VentureRadar
Offers innovative, non-opioid parenteral solutions for effective pain relief, reducing dependency on opioids and enhancing patient recovery. " Isosceles Pharmaceuticals is a specialty …See details»
Isosceles Pharmaceuticals Overview | SignalHire Company Profile
Organization Website: isoscelespharma.com : Isosceles Pharmaceut... industries Pharma: Headquarters Location: 1213 Culbreth Dr, Wilmington, North Carolina, 28405 US 1213 …See details»
Isosceles Pharmaceuticals - Overview, News & Similar ... - ZoomInfo
Oct 12, 2021 www.isoscelespharma.com. Revenue <$5 Million. Industry Manufacturing General Manufacturing . Recent News & Media. Isosceles Pharmaceuticals Signs Non-Binding Letter …See details»
Isosceles Pharmaceuticals Company Profile | Management and
[email protected]: Isosceles Pharmaceuticals Top Competitors. Company Employees Revenue Top technologies; Neumentum. 10: $964 K: Sciecure Pharma. 26: $4.5 …See details»
Isosceles Pharmaceuticals Inc. | North Carolina Biotech Center
Isosceles Pharmaceuticals is a specialty pharmaceutical company developing novel therapeutics for pain indications.See details»
Isosceles Pharmaceuticals - Products, Competitors, Financials ...
Isoscelespharma.com. Overview & Products; Financials; People; Founded Year 2019. Stage Grant | Alive. Total Raised $4.99M. About Isosceles Pharmaceuticals. Isosceles …See details»
Pipeline - Isosceles Pharmaceuticals, Inc.
Isosceles has pioneered a proprietary intravenous formulation based on our synthetic cannabidiol through a patented cGMP-compliant synthetic manufacturing process.See details»
Isosceles Pharmaceuticals, Inc. Appoints William D. Humphries as …
WILMINGTON, N.C., May 5, 2021 /PRNewswire/ -- Isosceles Pharmaceuticals Inc. a biotechnology company dedicated to developing, commercializing, and marketingSee details»
Isosceles Pharmaceuticals Signs Non-Binding Letter of Intent With …
WILMINGTON, N.C., Oct. 31, 2022 /PRNewswire/ -- Isosceles Pharmaceuticals, Inc., a preclinical stage pharmaceutical company ("Isosceles", or the "Company") engaged in the development …See details»
Isosceles Pharmaceuticals Signs Non-Binding Letter of Intent With …
Isosceles Pharmaceuticals, Inc., a preclinical stage pharmaceutical company ("Isosceles", or the "Company") engaged in the development of synthetic cannabidiol for the treatment of pain has …See details»
Isosceles Pharmaceuticals Signs Non-Binding Letter of Intent With …
“Further, the opportunity to partner with an established Contract Research Organization as part of our Phase 1 trials is a significant milestone for IPI 201 and will help us validate our proprietary …See details»
The hidden traps of business building: A guide for life science CEOs
3 days ago That kind of diligence works well to support mature companies but can stall new-business creation. To succeed with business building, life science companies must often …See details»
News - Isosceles Pharmaceuticals, Inc.
Seasoned pharmaceutical executive with more than 30 years of Commercial and Business Strategy experience Isosceles Pharmaceuticals Inc. a biotechnology company dedicated to …See details»